PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
The World Health Organization received Track 1 funding beginning in FY04 to provide technical assistance to the Blood Transfusion Service of Namibia (NAMBTS), Ministry of Health and Social Services (MoHSS), and Namibia Institute of Pathology (NIP). Following a needs assessment and situation analysis in FY04, which identified several technical assistance needs in terms of policy, guidelines, and associated training, substantial progress was made in FY05. A long-term WHO technical advisor (TA) with extensive experience on blood safety was assigned to Namibia. The WHO's role is mainly to provide technical support while NAMBTS, MoHSS and NIP are the implementers of the program. The first national Blood Policy was drafted following an extensive consensus-building process and is under review by the MoHSS policy committee. A major challenge has been bringing the NAMBTS, MoHSS, and NIP together for the first time to deliberate on respective roles and responsibilities, and the policy development process greatly facilitated development of those relationships. The TA has now facilitated the organization of a working group of relevant stakeholders to develop a national 5-year strategic plan for blood safety.
Major achievements in 2006 included assisting with development and launching of national guidelines for appropriate clinical use of blood and blood products, done in collaboration with MoHSS and NAMBTS. Other major areas of emphasis in FY06 were approval and dissemination of the first National Blood Policy; finalizing the blood transfusion draft legislation, development of the first blood safety 5-year strategic plan; supporting blood collection points to increase donors; and technical assistance to facilitate training of NAMBTS, MoHSS, and NIP staff on their respective responsibilities in quality management, component production, counseling of clients; supervisory skills, and assessing the cost-effectiveness of localizing testing of donor blood for transfusion transmitted infections (TTI), currently all TTI screening is being done in South Africa. Major targets for next year will be continuing to support the role out of the stated programs to regional level and strengthening of all the systems including setting up data and information systems to assist with monitoring and evaluation, and haemovigilance.
